Correlation Between Verastem and Rani Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verastem and Rani Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verastem and Rani Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verastem and Rani Therapeutics Holdings, you can compare the effects of market volatilities on Verastem and Rani Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verastem with a short position of Rani Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verastem and Rani Therapeutics.

Diversification Opportunities for Verastem and Rani Therapeutics

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Verastem and Rani is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Verastem and Rani Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rani Therapeutics and Verastem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verastem are associated (or correlated) with Rani Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rani Therapeutics has no effect on the direction of Verastem i.e., Verastem and Rani Therapeutics go up and down completely randomly.

Pair Corralation between Verastem and Rani Therapeutics

Given the investment horizon of 90 days Verastem is expected to generate 1.17 times more return on investment than Rani Therapeutics. However, Verastem is 1.17 times more volatile than Rani Therapeutics Holdings. It trades about -0.03 of its potential returns per unit of risk. Rani Therapeutics Holdings is currently generating about -0.05 per unit of risk. If you would invest  649.00  in Verastem on November 2, 2024 and sell it today you would lose (27.00) from holding Verastem or give up 4.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Verastem  vs.  Rani Therapeutics Holdings

 Performance 
       Timeline  
Verastem 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Verastem are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Verastem displayed solid returns over the last few months and may actually be approaching a breakup point.
Rani Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rani Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Verastem and Rani Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verastem and Rani Therapeutics

The main advantage of trading using opposite Verastem and Rani Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verastem position performs unexpectedly, Rani Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rani Therapeutics will offset losses from the drop in Rani Therapeutics' long position.
The idea behind Verastem and Rani Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA